Concentration-Dependent Efficacy of Recombinant Human Bone Morphogenetic Protein-2 Using a HA/β-TCP Hydrogel Carrier in a Mini-Pig Vertebral Oblique Lateral Interbody Fusion Model
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24010892 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Hye-Yeong Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Spine & Spinal Cord Institute, Department of Neurosurgery, College of Medicine, Yonsei University, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 2, Recombinant Proteins, Spinal Fusion. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, Korea Institute for Advancement of Technology, CGBio Co., Ltd.
Abstract (Originalsprache)
Bone morphogenetic protein-2 (BMP-2) is used in the treatment of degenerative spinal disease and vertebral fractures, spine fusion, dental surgery, and facial surgery. However, high doses are associated with side effects such as inflammation and osteophytes. In this study, we performed spinal fusion surgery on mini-pigs using BMP-2 and a HA/β-TCP hydrogel carrier, and evaluated the degree of fusion and osteophyte growth according to time and dosage. Increasing the dose of BMP-2 led to a significantly higher fusion rate than was observed in the control group, and there was no significant difference between the 8-week and 16-week samples. We also found that the HA + β-TCP hydrogel combination helped maintain the rate of BMP-2 release. In conclusion, the BMP-2-loaded HA/β-TCP hydrogel carrier used in this study overcame the drawback of potentially causing side effects when used at high concentrations by enabling the sustained release of BMP-2. This method is also highly efficient, since it provides mineral matter to accelerate the fusion rate of the spine and improve bone quality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Spine & Spinal Cord Institute, Department of Neurosurgery, College of Medicine, Yonsei University, Seoul 03722, Republic of Korea.
- Department of Neurosurgery, Yongin Severance Hospital, Yonsei University College of Medicine, 363, Yongin-si 16995, Republic of Korea.
- POSTECH Biotech Center, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.
ORCID-Profile: Hye-Yeong Lee
Förderung
- Korea Health Industry Development Institute
- Korea Institute for Advancement of Technology
- CGBio Co., Ltd
Zitieren
APA
Lee, H. Y., Kang, J. I., Lee, H. L., Hwang, G. Y., Kim, K. N., & Ha, Y. (2023). Concentration-Dependent Efficacy of Recombinant Human Bone Morphogenetic Protein-2 Using a HA/β-TCP Hydrogel Carrier in a Mini-Pig Vertebral Oblique Lateral Interbody Fusion Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24010892
Vancouver
Lee HY, Kang JI, Lee HL, Hwang GY, Kim KN, Ha Y. Concentration-Dependent Efficacy of Recombinant Human Bone Morphogenetic Protein-2 Using a HA/β-TCP Hydrogel Carrier in a Mini-Pig Vertebral Oblique Lateral Interbody Fusion Model. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24010892
BibTeX
@article{Lee2023,
author = {Lee, Hye-Yeong and Kang, Ji-In and Lee, Hye-Lan and Hwang, Gwang-Yong and Kim, Keung-Nyun and Ha, Yoon},
title = {Concentration-Dependent Efficacy of Recombinant Human Bone Morphogenetic Protein-2 Using a HA/β-TCP Hydrogel Carrier in a Mini-Pig Vertebral Oblique Lateral Interbody Fusion Model},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24010892}
}
EUVIMED